Korea University Guro Hospital
Clinical Trials
89
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (68 trials with phase data)• Click on a phase to view related trials
OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in Stable Angina
- Conditions
- Stable AnginaCoronary Artery Disease
- Interventions
- First Posted Date
- 2025-09-30
- Last Posted Date
- 2025-09-30
- Lead Sponsor
- Korea University Guro Hospital
- Target Recruit Count
- 130
- Registration Number
- NCT07198529
- Locations
- 🇰🇷
Cardiovascular Center, Department of Internal Medicine, Korea University Guro Hospital, Seoul, Gurodong-ro, Guro-gu, South Korea
Evaluation of an Opioid Stewardship Program in Non-Cancer Patients
- Conditions
- PainChronic PainOpioid AnalgesiaOpioid Use
- First Posted Date
- 2025-08-03
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- Korea University Guro Hospital
- Target Recruit Count
- 70
- Registration Number
- NCT07102446
- Locations
- 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of
Subcostal Single-port Versus Intercostal Multi-port Robotic Lobectomy for Non-small Cell Lung Cancer
- Conditions
- Non Small Cell Lung Cancer
- First Posted Date
- 2025-08-01
- Last Posted Date
- 2025-08-01
- Lead Sponsor
- Korea University Guro Hospital
- Target Recruit Count
- 339
- Registration Number
- NCT07099105
- Locations
- 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of
AI-Driven Precision Diagnostic System for Lung Cancer Based on Liquid Biopsy
- Conditions
- Lung Cancer
- First Posted Date
- 2025-06-08
- Last Posted Date
- 2025-06-08
- Lead Sponsor
- Korea University Guro Hospital
- Target Recruit Count
- 865
- Registration Number
- NCT07009769
- Locations
- 🇰🇷
Korea University Guro Hospital, Guro-gu, Seoul, Korea, Republic of
Efficacy and Safety of CBT on Tinnitus
- Conditions
- Tinnitus
- First Posted Date
- 2025-03-21
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Korea University Guro Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT06889259
- Locations
- 🇰🇷
Korea University Guro Hospital, Seoul, Korea, Republic of
- Prev
- 1
- 2
- 3
- 4
- 5
- 17
- Next
News
Onconic's Jaqbo Shows 100% Efficacy in Phase 3 Gastric Ulcer Trial, Seeks Indication Expansion
Onconic Therapeutics has submitted an application to MFDS to expand Jaqbo's indication to include gastric ulcer treatment, following successful Phase 3 trial results showing 100% healing rate at 8 weeks.